Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalia

Showing results (31-40 of 2,599) with videos related to

Pageof 260
Sort By:
Pflugers Archiv : European Journal of Physiology|November 8, 1973
Effects of certain cerebral lesions on the J reflexM Kalia
Metabolism: Clinical and Experimental|September 19, 2006
Neurobiology of sleepMadhu Kalia
Brain Research|May 10, 1991
Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axonsM Kalia
Brain Communications|July 2, 2026
Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's diseaseMinesh Kapadia, Lorraine V Kalia, Suneil K Kalia
CNS & Neurological Disorders Drug Targets|October 15, 2010
Molecular chaperones as rational drug targets for Parkinson's disease therapeuticsS K Kalia, L V Kalia, P J McLean
The Lancet. Neurology|July 19, 2008
NMDA receptors in clinical neurology: excitatory times aheadLorraine V Kalia, Suneil K Kalia, Michael W Salter
British Journal of Pharmacology|May 4, 2018
Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V Kalia
Critical Reviews in Clinical Laboratory Sciences|March 3, 2020
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V Kalia
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Disease-modifying strategies for Parkinson's diseaseLorraine V Kalia, Suneil K Kalia, Anthony E Lang
Physical Review. B, Condensed Matter|April 15, 1988
Structural correlations in silicon microclustersFeuston, Kalia, Vashishta
Pageof 260

Showing results (31-40 of 2,599) with videos related to

Sort By:
Pageof 260
Pflugers Archiv : European Journal of Physiology|November 8, 1973
Effects of certain cerebral lesions on the J reflexM Kalia
Metabolism: Clinical and Experimental|September 19, 2006
Neurobiology of sleepMadhu Kalia
Brain Research|May 10, 1991
Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axonsM Kalia
Brain Communications|July 2, 2026
Modulating α-synuclein clearance: a comparison of high-frequency and direct current stimulation in preclinical models of Parkinson's diseaseMinesh Kapadia, Lorraine V Kalia, Suneil K Kalia
CNS & Neurological Disorders Drug Targets|October 15, 2010
Molecular chaperones as rational drug targets for Parkinson's disease therapeuticsS K Kalia, L V Kalia, P J McLean
The Lancet. Neurology|July 19, 2008
NMDA receptors in clinical neurology: excitatory times aheadLorraine V Kalia, Suneil K Kalia, Michael W Salter
British Journal of Pharmacology|May 4, 2018
Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V Kalia
Critical Reviews in Clinical Laboratory Sciences|March 3, 2020
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's diseaseDarren M O'Hara, Suneil K Kalia, Lorraine V Kalia
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Disease-modifying strategies for Parkinson's diseaseLorraine V Kalia, Suneil K Kalia, Anthony E Lang
Physical Review. B, Condensed Matter|April 15, 1988
Structural correlations in silicon microclustersFeuston, Kalia, Vashishta
Pageof 260